Global skin disease morbidity and mortality an update from the global burden of disease study 2013

JAMA Dermatology

Volumn 153, Issue 5, 2017, Pages 406-412

  Karimkhani, Chante ^a,b   Dellavalle, Robert P ^b,c,d   Coffeng, Luc E ^e,f   Flohr, Carsten ^g   Hay, Roderick J ^h   Langan, Sinéad M ⁱ   Nsoesie, Elaine O ^e   Ferrari, Alize J ^e,j,k   Erskine, Holly E ^e,j,k   Silverberg, Jonathan I ^a,l   Vos, Theo ^e   Naghavi, Mohsen ^e  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^h KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^j UNIVERSITY OF QUEENSLAND   (Australia)

^k Queensland Centre for Mental Health Research   (Australia)

^l NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; ALOPECIA AREATA; ARTICLE; ATOPIC DERMATITIS; CELLULITIS; CONTACT DERMATITIS; DEATH; DECUBITUS; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; GLOBAL DISEASE BURDEN; HUMAN; INCIDENCE; MELANOMA; MORBIDITY; MORTALITY; MORTALITY RISK; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PYODERMA; REMISSION; SCABIES; SEBORRHEIC DERMATITIS; SKIN DISEASE; URTICARIA; VIRAL SKIN DISEASE; ADOLESCENT; ADULT; AGED; BAYES THEOREM; CHILD; DISABLED PERSON; FEMALE; GLOBAL HEALTH; INFANT; MALE; MIDDLE AGED; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; QUALITY ADJUSTED LIFE YEAR; SKIN DISEASES; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; CHILD; CHILD, PRESCHOOL; DISABLED PERSONS; FEMALE; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; SKIN DISEASES; YOUNG ADULT;

EID: 85018979941     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2016.5538     Document Type: Article

References (29)

1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448-457.
2. Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063-2066.
3. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012; 380(9859):2197-2223.
4. Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy. Seattle,WA: Institute for Health Metrics and Evaluation; 2013.
5. Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527-1534.
6. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.
7. Neal RD, Cannings-John R, Hood K, et al. Excision of malignant melanomas in NorthWales: effect of location and surgeon on time to diagnosis and quality of excision. FamPract. 2008;25(4):221-227.
8. Nolan RC, Chan MT, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers inWestern Australia. J AmAcad Dermatol. 2005;52(1):101-108.
9. National Cancer Institute. SEER cancer statistics review 1975-2013. https://seer.cancer.gov/csr/1975 -2013/. Accessed May 16, 2016.
10. Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the global burden of disease 2013 study. Lancet Glob Health. 2015;3(11):e712-e723.
11. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-171.
12. United Nations.World population prospects: 2015 revision. http://esa.un.org/unpd/wpp/publications/files/key-findings-wpp-2015.pdf. Accessed February 17, 2016.
13. GBD Compare. https://vizhub.healthdata.org/gbd-compare/. Accessed April 1, 2016.
14. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.
15. Murray CJ, Barber RM, Foreman KJ, et al; GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145-2191.
16. Institute for Health Metrics and Evaluation (IHME). Financing Global Health 2015: Development Assistance Steady on the Path to New Global Goals. Seattle,WA: IHME; 2016.
17. International Federation of Dermatology Clinical Trials Networks. About the Federation. http://www.ifdctn.org/about-the-federation/about.aspx. Accessed January 26, 2017.
18. Robson KJ, PietteWW. Cutaneous manifestations of systemic diseases. Med Clin North Am. 1998;82(6):1359-1379.
19. Hay RJ, Augustin M, Griffiths CE, SterryW; Board of the International League of Dermatological Societies and the Grand Challenges Consultation groups. The global challenge for skin health. Br J Dermatol. 2015;172(6):1469-1472.
20. Freeman EE. A seat at the big table: expanding the role of dermatology at theWorld Health Organization and beyond. J Invest Dermatol. 2014; 134(11):2663-2665.
21. The International Foundation for Dermatology. Our aim. http://www.ifd.org. Accessed August 31, 2016.
22. UNAIDS. The Gap Report. http://www.unaids .org/sites/default/files/media-asset/UNAIDS-Gap -report-en.pdf. Accessed August 30, 2016.
23. Lekalakala PT, Khammissa RA, Kramer B, Ayo-Yusuf OA, Lemmer J, Feller L. Oculocutaneous albinism and squamous cell carcinoma of the skin of the head and neck in sub-Saharan Africa. J Skin Cancer. 2015;2015:167847.
24. International Foundation for Dermatology. Progress report 2015-16. http://www.ifd.org/IFD/media/IFD/Misc/IFD-Progress-Report-2015-2016 .pdf. Accessed September 2, 2016.
25. The Cochrane Collaboration. About us. http://www.cochrane.org/about-us. Accessed August 30, 2016.
26. Cochrane Skin. Prioritisation of dermatological research. http://skin.cochrane.org/prioritisation-dermatological-research. Accessed August 30, 2016.
27. Karimkhani C, Boyers LN, Prescott L, et al. Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews. JAMA Dermatol. 2014;150(9):945-951.
28. Shiffman J. Knowledge, moral claims and the exercise of power in global health. Int J Health Policy Manag. 2014;3(6):297-299.
29. Rudan I, Chan KY. Global health metrics needs collaboration and competition. Lancet. 2015;385 (9963):92-94.